Acer Therapeutics Analysis

ACERDelisted Stock  USD 0.81  0.10  14.08%   
Acer Therapeutics is overvalued with Real Value of 0.74 and Hype Value of 0.81. The main objective of Acer Therapeutics delisted stock analysis is to determine its intrinsic value, which is an estimate of what Acer Therapeutics is worth, separate from its market price. There are two main types of Acer Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Acer Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Acer Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Acer Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Acer Therapeutics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Acer Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Acer Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

Acer Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.98. Acer Therapeutics last dividend was issued on the 21st of September 2017. The entity had 96:1000 split on the 21st of September 2017. Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. For more info on Acer Therapeutics please contact Christopher Schelling at 844 902 6100 or go to https://www.acertx.com.

Acer Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Acer Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Acer Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Acer Therapeutics is not yet fully synchronised with the market data
Acer Therapeutics has some characteristics of a very speculative penny stock
Acer Therapeutics has a very high chance of going through financial distress in the upcoming years
The company currently holds 11.86 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Acer Therapeutics has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acer Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Acer Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acer Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acer to invest in growth at high rates of return. When we think about Acer Therapeutics' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (26.24 M) with profit before overhead, payroll, taxes, and interest of 1.26 M.
Acer Therapeutics currently holds about 14.47 M in cash with (30.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 14.0% of Acer Therapeutics shares are held by company insiders

Acer Therapeutics Upcoming and Recent Events

Earnings reports are used by Acer Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Acer Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of November 2023
Upcoming Quarterly Report
View
25th of March 2024
Next Financial Report
View
30th of September 2023
Next Fiscal Quarter End
View
25th of March 2024
Next Fiscal Year End
View
30th of June 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Acer Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.02 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Acer Therapeutics's market, we take the total number of its shares issued and multiply it by Acer Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Acer Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Acer Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Acer Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Acer Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Acer Therapeutics Predictive Daily Indicators

Acer Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Acer Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Acer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Acer Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Acer shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Acer Therapeutics. By using and applying Acer Stock analysis, traders can create a robust methodology for identifying Acer entry and exit points for their positions.
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Acer Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Acer Therapeutics information on this page should be used as a complementary analysis to other Acer Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Acer Stock

If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data